Exact Sciences is committed to helping win the war on cancer through early detection.

Learn More

Cologuard: the first and only FDA approved stool DNA noninvasive colorectal cancer screening test.*

Learn More about Cologuard
*For average risk individuals only. Click the link above and talk to your doctor to see if Cologuard is right for you.

Latest News

View Webcast Archive and Slides from Exact Sciences' Conference Call Regarding USPSTF Draft Recommendations

Exact Sciences Corp. today hosted a webcast and conference call to discuss the U.S. Preventive Services Task Force release of its draft recommendations regarding colorectal cancer screening. You can listen to a webcast archive by following this link, or view the presentation slides are below. Regarding U.S. Preventive Services Task Force Draft Recommendations from Exact...Read more

CMS Issues Preliminary Determination Maintaining Cologuard® Reimbursement Rate

MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the Centers for Medicare and Medicaid Services (CMS) issued a preliminary determination maintaining the current reimbursement rate for Cologuard, the company's non-invasive, stool DNA-based colon cancer screening test. CMS considered reimbursement for a new CPT billing code for Cologuard (81528), as well as...Read more

Be Seen, Get Screened
1 in 3 is not getting screened for colon cancer. Let's bring everyone out of hiding and in to get screened. Join us on Be Seen, Get Screened to help spread the word.

Exact Sciences Laboratories is dedicated to delivering the most accurate results and providing physicians and patients with world-class service.

Go To ExactLabs.com


View updates on upcoming conference appearances, company news, financial reports and more.

Learn More